The current role of Omega-3 fatty acids in the management of atrial fibrillation

International Journal of Molecular Sciences

Volumn 16, Issue 9, 2015, Pages 22870-22887

  Christou, Georgios A ^a   Christou, Konstantinos A ^b   Korantzopoulos, Panagiotis ^b   Rizos, Evangelos C ^b   Nikas, Dimitrios N ^b   Goudevenos, John A ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Arrhythmia; Atrial fibrillation; Cardiac surgery; Cardioversion; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FARNESOID X RECEPTOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; RETINOID X RECEPTOR; VOLTAGE GATED SODIUM CHANNEL; ANTIARRHYTHMIC AGENT;

ATRIAL FIBRILLATION; CARDIOVERSION; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD FREQUENCY QUESTIONNAIRE; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART MUSCLE REFRACTORY PERIOD; HEART SURGERY; HUMAN; HYPERTENSION; REVIEW; UPREGULATION; ADVERSE EFFECTS; ANALYSIS; ANIMAL; DIETARY SUPPLEMENT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 84942163545     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160922870     Document Type: Review

References (74)

1. Colussi, G.; Catena, C.; Baroselli, S.; Nadalini, E.; Lapenna, R.; Chiuch, A.; Sechi, L.A. Omega-3 fatty acids: From biochemistry to their clinical use in the prevention of cardiovascular disease. Recent Pat. Cardiovasc. Drug Discov. 2007, 2, 13–21.
2. Williams, C.M.; Burdge, G. Long-chain n-3 PUFA: Plant v. marine sources. Proc. Nutr. Soc. 2006, 65, 42–50.
3. Christou, G.A.; Rizos, E.C.; Mpechlioulis, A.; Penzo, C.; Pacchioni, A.; Nikas, D.N. Confronting the residual cardiovascular risk beyond statins: The role of fibrates, omega-3 fatty acids, or niacin, in diabetic patients. Curr. Pharm. Des. 2014, 20, 3675–3688.
4. Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 2012, 308, 1024–1033.
5. Savelieva, I.; Kourliouros, A.; Camm, J. Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: Review of evidence and clinical relevance. Naunyn Schmiedeberg’s Arch. Pharmacol. 2010, 381, 1–13.
6. Wilbring, M.; Ploetze, K.; Bormann, S.; Waldow, T.; Matschke, K. Omega-3 polyunsaturated Fatty acids reduce the incidence of postoperative atrial fibrillation in patients with history of prior myocardial infarction undergoing isolated coronary artery bypass grafting. Thorac. Cardiovasc. Surg. 2014, 62, 569–574.
7. Calò, L.; Bianconi, L.; Colivicchi, F.; Lamberti, F.; Loricchio, M.L.; de Ruvo, E.; Meo, A.; Pandozi, C.; Staibano, M.; Santini, M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial. J. Am. Coll. Cardiol. 2005, 45, 1723–1728.
8. Heidt, M.C.; Vician, M.; Stracke, S.K.; Stadlbauer, T.; Grebe, M.T.; Boening, A.; Vogt, P.R.; Erdogan, A. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A prospective randomized study. Thorac. Cardiovasc. Surg. 2009, 57, 276–280.
9. Rodrigo, R.; Korantzopoulos, P.; Cereceda, M.; Asenjo, R.; Zamorano, J.; Villalabeitia, E.; Baeza, C.; Aguayo, R.; Castillo, R.; Carrasco, R et al. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. J. Am. Coll. Cardiol. 2013, 62, 1457–1465.
10. Kumar, S.; Sutherland, F.; Morton, J.B.; Lee, G.; Morgan, J.; Wong, J.; Eccleston, D.E.; Voukelatos, J.; Garg, M.L.; Sparks, P.B. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm. 2012, 9, 483–491.
11. Nodari, S.; Triggiani, M.; Campia, U.; Manerba, A.; Milesi, G.; Cesana, B.M.; Gheorghiade, M.; dei Cas, L. N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: A prospective, randomized study. Circulation 2011, 124, 1100–1106.
12. European Heart Rhythm Association1; European Association for Cardio-Thoracic Surgery; Camm, A.J.; Kirchhof, P.; Lip, G.Y.; Schotten, U.; Savelieva, I.; Ernst, S.; van Gelder, I.C.; Al-Attar, N et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010, 12, 1360–1420.
13. Burdge, G.C. Metabolism of α-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 161–168.
14. Virtanen, J.K.; Mursu, J.; Voutilainen, S.; Tuomainen, T.P. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009, 120, 2315–2321.
15. Iwasaki, Y.K.; Nishida, K.; Kato, T.; Nattel, S. Atrial fibrillation pathophysiology: Implications for management. Circulation 2011, 124, 2264–2274.
16. Ramadeen, A.; Connelly, K.A.; Leong-Poi, H.; Hu, X.; Fujii, H.; Laurent, G.; Domenichiello, A.F.; Bazinet, R.P.; Dorian, P. Docosahexaenoic acid, but not eicosapentaenoic acid, supplementation reduces vulnerability to atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2012, 5, 978–983.
17. Lau, D.H.; Psaltis, P.J.; Carbone, A.; Kelly, D.J.; Mackenzie, L.; Worthington, M.; Metcalf, R.G.; Kuklik, P.; Nelson, A.J.; Zhang, Y et al. Atrial protective effects of n-3 polyunsaturated fatty acids: A long-term study in ovine chronic heart failure. Heart Rhythm. 2011, 8, 575–582.
18. Kumar, S.; Sutherland, F.; Rosso, R.; The, A.W.; Lee, G.; Heck, P.M.; Feldman, A.; Medi, C.; Watt, S.; Garg, M.L et al. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm. 2011, 8, 562–568.
19. Laurent, G.; Moe, G.; Hu, X.; Holub, B.; Leong-Poi, H.; Trogadis, J.; Connelly, K.; Courtman, D.; Strauss, B.H.; Dorian, P. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc. Res. 2008, 77, 89–97.
20. Kitamura, K.; Shibata, R.; Tsuji, Y.; Shimano, M.; Inden, Y.; Murohara, T. Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H1814–H1821.
21. Kumar, S.; Sutherland, F.; Teh, A.W.; Heck, P.M.; Lee, G.; Garg, M.L.; Sparks, P.B. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation. Am. J. Cardiol. 2011, 108, 531–535.
22. Da Cunha, D.N.; Hamlin, R.L.; Billman, G.E.; Carnes, C.A. n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br. J. Pharmacol. 2007, 150, 281–285.
23. Ninio, D.M.; Murphy, K.J.; Howe, P.R.; Saint, D.A. Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. J. Cardiovasc. Electrophysiol. 2005, 16, 1189–1194.
24. Mayyas, F.; Sakurai, S.; Ram, R.; Rennison, J.H.; Hwang, E.S.; Castel, L.; Lovano, B.; Brennan, M.L.; Bibus, D.; Lands, B. et al. Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model. Cardiovasc. Res. 2011, 89, 852–861.
25. Zhang, Z.; Zhang, C.; Wang, H.; Zhao, J.; Liu, L.; Lee, J.; He, Y.; Zheng, Q. n-3 polyunsaturated fatty acids prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Int. J. Cardiol. 2011, 153, 14–20.
26. Li, G.R.; Sun, H.Y.; Zhang, X.H.; Cheng, L.C.; Chiu, S.W.; Tse, H.F.; Lau, C.P. Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+ currents and Na+ current in human atrial myocytes. Cardiovasc. Res. 2009, 81, 286–293.
27. Moreno, C.; Macías, A.; Prieto, A.; de la Cruz, A.; González, T.; Valenzuela, C. Effects of n-3 polyunsaturated fatty acids on cardiac ion channels. Front. Physiol. 2012, 3, 245, doi:10.3389/fphys.2012.00245.
28. Suenari, K.; Chen, Y.C.; Kao, Y.H.; Cheng, C.C.; Lin, Y.K.; Kihara, Y.; Chen, Y.J.; Chen, S.A. Eicosapentaenoic acid reduces the pulmonary vein arrhythmias through nitric oxide. Life Sci. 2011, 89, 129–36.
29. Jahangiri, A.; Leifert, W.R.; Patten, G.S.; McMurchie, E.J. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol. Cell. Biochem. 2000, 206, 33–41.
30. Sarrazin, J.F.; Comeau, G.; Daleau, P.; Kingma, J.; Plante, I.; Fournier, D.; Molin, F. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J. Am. Coll. Cardiol. 2007, 50, 1505–1512.
31. Ramadeen, A.; Laurent, G.; dos Santos, C.C.; Hu, X.; Connelly, K.A.; Holub, B.J.; Mangat, I.; Dorian, P. n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm. 2010, 7, 520–528.
32. Sakabe, M.; Shiroshita-Takeshita, A.; Maguy, A.; Dumesnil, C.; Nigam, A.; Leung, T.K.; Nattel, S. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 2007, 116, 2101–2209.
33. Ramadeen, A.; Connelly, K.A.; Leong-Poi, H.; Hu, X.; Fujii, H.; van Krieken, R.; Laurent, G.; Holub, B.J.; Bazinet, R.P.; Dorian, P. N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria. Heart Rhythm. 2012, 9, 1115–1122.
34. Den Ruijter, H.M.; Berecki, G.; Opthof, T.; Verkerk, A.O.; Zock, P.L.; Coronel, R. Pro-and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc. Res. 2007, 73, 316–325.
35. Metcalf, R.G.; James, M.J.; Gibson, R.A.; Edwards, J.R.; Stubberfield, J.; Stuklis, R.; Roberts-Thomson, K.; Young, G.D.; Cleland, L.G. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am. J. Clin. Nutr. 2007, 85, 1222–1228.
36. Kumar, S.; Sutherland, F.; Lee, J.M.; Robinson, T.; Heck, P.M.; Wong, M.C.; Kelland, N.F.; Garg, M.L.; Sparks, P.B. Effects of high dose intravenous fish oil on human atrial electrophysiology: Implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation. Int. J. Cardiol. 2013, 168, 2754–2760.
37. Massaro, M.; Scoditti, E.; Carluccio, M.A.; de Caterina, R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79, 109–115.
38. McLennan, P.L. Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 2001, 36, S111–S114.
39. De Caterina, R.; Bernini, W.; Carluccio, M.A.; Liao, J.K.; Libby, P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J. Lipid Res. 1998, 39, 1062–1070.
40. De Urquiza, A.M.; Liu, S.; Sjöberg, M.; Zetterström, R.H.; Griffiths, W.; Sjövall, J.; Perlmann, T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290, 2140–2144.
41. Burdge, G. Alpha-linolenic acid metabolism in men and women: Nutritional and biological implications. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7, 137–144.
42. Kumar, S.; Sutherland, F.; Wheeler, M.; Heck, P.M.; Lee, G.; The, A.W.; Garg, M.L.; Morgan, J.G.; Sparks, P.B. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial mechanical function after reversion of atrial arrhythmias to sinus rhythm: Reversal of tachycardia-mediated atrial cardiomyopathy with fish oils. Heart Rhythm.2011, 8, 643–649.
43. Gronroos, N.N.; Chamberlain, A.M.; Folsom, A.R.; Soliman, E.Z.; Agarwal, S.K.; Nettleton, J.A.; Alonso, A. Fish, fish-derived n-3 fatty acids, and risk of incident atrial fibrillation in the Atherosclerosis Risk in Communities (ARIC) study. PLoS ONE. 2012, 7, e36686.
44. Berry, J.D.; Prineas, R.J.; van Horn, L.; Passman, R.; Larson, J.; Goldberger, J.; Snetselaar, L.; Tinker, L.; Liu, K.; Lloyd-Jones, D.M. Dietary fish intake and incident atrial fibrillation (from the Women’s Health Initiative). Am. J. Cardiol. 2010, 105, 844–848.
45. Brouwer, I.A.; Heeringa, J.; Geleijnse, J.M.; Zock, P.L.; Witteman, J.C. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am. Heart. J. 2006, 151, 857–862.
46. Frost, L.; Vestergaard, P. n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am. J. Clin. Nutr. 2005, 81, 50–54.
47. Shen, J.; Johnson, V.M.; Sullivan, L.M.; Jacques, P.F.; Magnani, J.W.; Lubitz, S.A.; Pandey, S.; Levy, D.; Vasan, R.S.; Quatromoni, P.A et al. Dietary factors and incident atrial fibrillation: The Framingham Heart Study. Am. J. Clin. Nutr. 2011, 93, 261–266.
48. Wu, J.H.; Lemaitre, R.N.; King, I.B.; Song, X.; Sacks, F.M.; Rimm, E.B.; Heckbert, S.R.; Siscovick, D.S.; Mozaffarian, D. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: The cardiovascular health study. Circulation 2012, 125, 1084–1093.
49. Mozaffarian, D.; Psaty, B.M.; Rimm, E.B.; Lemaitre, R.N.; Burke, G.L.; Lyles, M.F.; Lefkowitz, D.; Siscovick, D.S. Fish intake and risk of incident atrial fibrillation. Circulation 2004, 110, 368–373.
50. Williams, M.J.; Sutherland, W.H.; McCormick, M.P.; de Jong, S.A.; Walker, R.J.; Wilkins, G.T. Impaired endothelial function following a meal rich in used cooking fat. J. Am. Coll. Cardiol. 1999, 33, 1050–1055.
51. Mozaffarian, D.; Lemaitre, R.N.; Kuller, L.H.; Burke, G.L.; Tracy, R.P.; Siscovick, D.S. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: The Cardiovascular Health Study. Circulation 2003, 107, 1372–1377.
52. Christensen, J.H.; Gustenhoff, P.; Korup, E.; Aarøe, J.; Toft, E.; Møller, J.; Rasmussen, K.; Dyerberg, J.; Schmidt, E.B. Effect of fish oil on heart rate variability in survivors of myocardial infarction: A double blind randomised controlled trial. BMJ 1996, 312, 677–678.
53. London, B.; Albert, C.; Anderson, M.E.; Giles, W.R.; van Wagoner, D.R.; Balk, E.; Billman, G.E.; Chung, M.; Lands, W.; Leaf, A et al. Omega-3 fatty acids and cardiac arrhythmias: Prior studies and recommendations for future research: A report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 2007, 116, e320–e335.
54. Lomivorotov, V.V.; Efremov, S.M.; Pokushalov, E.A.; Romanov, A.B.; Ponomarev, D.N.; Cherniavsky, A.M.; Shilova, A.N.; Karaskov, A.M.; Lomivorotov, V.N. Randomized trial of fish oil infusion to prevent atrial fibrillation after cardiac surgery: Data from an implantable continuous cardiac monitor. J. Cardiothorac. Vasc. Anesth. 2014, 28, 1278–1284.
55. Sandesara, C.M.; Chung, M.K.; van Wagoner, D.R.; Barringer, T.A.; Allen, K.; Ismail, H.M.; Zimmerman, B.; Olshansky, B. A randomized, placebo-controlled trial of omega-3 fatty acids for inhibition of supraventricular arrhythmias after cardiac surgery: the FISH trial. J. Am. Heart Assoc. 2012, 1, e000547, doi:10.1161/JAHA.111.000547.
56. Mozaffarian, D.; Marchioli, R.; Macchia, A.; Silletta, M.G.; Ferrazzi, P.; Gardner, T.J.; Latini, R.; Libby, P.; Lombardi, F.; O’Gara, P.T et al. Fish oil and postoperative atrial fibrillation: The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 2012, 308, 2001–2011.
57. Heidarsdottir, R.; Arnar, D.O.; Skuladottir, G.V.; Torfason, B.; Edvardsson, V.; Gottskalksson, G.; Palsson, R.; Indridason, O.S. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 2010, 12, 356–363.
58. Yamamoto, T.; Kajikawa, Y.; Otani, S.; Yamada, Y.; Takemoto, S.; Hirota, M.; Ikeda, M.; Iwagaki, H.; Saito, S.; Fujiwara, T. Protective effect of eicosapentaenoic acid on insulin resistance in hyperlipidemic patients and on the postoperative course of cardiac surgery patients: The possible involvement of adiponectin. Acta Med. Okayama 2014, 68, 349–361.
59. Sorice, M.; Tritto, F.P.; Sordelli, C.; Gregorio, R.; Piazza, L. n-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing “on-pump” coronary artery bypass graft surgery. Monaldi. Arch. Chest. Dis. 2011, 76, 93–98.
60. Guo, X.Y.; Yan, X.L.; Chen, Y.W.; Tang, R.B.; Du, X.; Dong, J.Z.; Ma, C.S. Omega-3 fatty acids for postoperative atrial fibrillation: Alone or in combination with antioxidant vitamins? Heart Lung Circ. 2014, 23, 743–750.
61. Zhang, B.; Zhen, Y.; Tao, A.; Bao, Z.; Zhang, G. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: An updated meta-analysis of randomized controlled trials. J. Cardiol. 2014, 63, 53–59.
62. Costanzo, S.; di Niro, V.; di Castelnuovo, A.; Gianfagna, F.; Donati, M.B.; de Gaetano, G.; Iacoviello, L. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: An updated meta-analysis. J. Thorac. Cardiovasc. Surg. 2013, 146, 906–911.
63. Skuladottir, G.V.; Heidarsdottir, R.; Arnar, D.O.; Torfason, B.; Edvardsson, V.; Gottskalksson, G.; Palsson, R.; Indridason, O.S. Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. Eur. J. Clin. Investig. 2011, 41, 995–1003.
64. Darghosian, L.; Free, M.; Li, J.; Gebretsadik, T.; Bian, A.; Shintani, A.; McBride, B.F.; Solus, J.; Milne, G.; Crossley, G.H et al. Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. Am. J. Cardiol. 2015, 115, 196–201.
65. Nigam, A.; Talajic, M.; Roy, D.; Nattel, S.; Lambert, J.; Nozza, A.; Jones, P.; Ramprasath, V.R.; O’Hara, G.; Kopecky, S et al. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J. Am. Coll. Cardiol. 2014, 64, 1441–1448.
66. Macchia, A.; Grancelli, H.; Varini, S.; Nul, D.; Laffaye, N.; Mariani, J.; Ferrante, D.; Badra, R.; Figal, J.; Ramos, S et al. GESICA Investigators.Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: Results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. J. Am. Coll. Cardiol. 2013, 61, 463–468.
67. Kowey, P.R.; Reiffel, J.A.; Ellenbogen, K.A.; Naccarelli, G.V.; Pratt, C.M. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: A randomized controlled trial. JAMA 2010, 304, 2363–2372.
68. Kumar, S.; Sutherland, F.; Stevenson, I.; Lee, J.M.; Garg, M.L.; Sparks, P.B. Effects of long-term ω-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: Results from a prospective randomised study. Int. J. Cardiol. 2013, 168, 3812–3817.
69. Bianconi, L.; Calò, L.; Mennuni, M.; Santini, L.; Morosetti, P.; Azzolini, P.; Barbato, G.; Biscione, F.; Romano, P.; Santini, M. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: A randomized, double-blind, multicentre study. Europace 2011, 13, 174–181.
70. Ozaydın, M.; Erdoğan, D.; Tayyar, S.; Uysal, B.A.; Doğan, A.; Içli, A.; Ozkan, E.; Varol, E.; Türker, Y.; Arslan, A. n-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: A prospective randomized study. Anadolu Kardiyol. Derg. 2011, 11, 305–309.
71. Cao, H.; Wang, X.; Huang, H.; Ying, S.Z.; Gu, Y.W.; Wang, T.; Huang, C.X. Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: A meta-analysis of randomized controlled trials. Intern. Med. 2012, 51, 2503–2508.
72. Aleksova, A.; Masson, S.; Maggioni, A.P.; Lucci, D.; Fabbri, G.; Beretta, L.; Mos, L.; Paino, A.M.; Nicolosi, G.L.; Marchioli, R et al. n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: The GISSI-HF trial. Eur. J. Heart Fail. 2013, 15, 1289–1295.
73. Macchia, A.; Monte, S.; Pellegrini, F.; Romero, M.; Ferrante, D.; Doval, H.; D’Ettorre, A.; Maggioni, A.P.; Tognoni, G. Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur. J. Clin. Pharmacol. 2008, 64, 627–634.
74. Patel, D.; Shaheen, M.; Venkatraman, P.; Armaganijan, L.; Sanchez, J.E.; Horton, R.P.; di Biase, L.; Mohanty, P.; Canby, R.; Bailey, S.M et al. Omega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation. Indian Pacing Electrophysiol. J. 2009, 9, 292–298.